Skip to Main Content

Paper Details

Correction to: Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.
Leukemia
2
2021
Author NameAffiliation
Justin M WattsSylvester Comprehensive Cancer Center, University of Miami
Lionel Ad??s
Lionel Ad??sUniversity of Paris and INSERM U
  • 1 - 3

Datasets

Release 1.2